This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahalingam, S.
Right arrow Articles by Weiner, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahalingam, S.
Right arrow Articles by Weiner, D. B.

 Previous Article  |  Next Article 

J. Virol., 09 1997, 6339-6347, Vol 71, No. 9
Copyright © 1997, American Society for Microbiology

Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr

S Mahalingam, V Ayyavoo, M Patel, T Kieber-Emmons and DB Weiner
Department of Pathology, School of Medicine, University of Pennsylvania Medical Center, Philadelphia 19104, USA.

The vpr gene product of human immunodeficiency virus type 1 (HIV-1) is a virion-associated protein that is essential for efficient viral replication in monocytes/macrophages. Vpr is primarily localized in the nucleus when expressed in the absence of other viral proteins. Vpr is packaged efficiently into viral particles through interactions with the p6 domain of the Gag precursor polyprotein p55gag. We developed a panel of expression vectors encoding Vpr molecules mutated in the amino- terminal helical domain, leucine-isoleucine (LR) domain, and carboxy- terminal domain to map the different functional domains and to define the interrelationships between virion incorporation, nuclear localization, cell cycle arrest, and differentiation functions of Vpr. We observed that substitution mutations in the N-terminal domain of Vpr impaired both nuclear localization and virion packaging, suggesting that the helical structure may play a vital role in modulating both of these biological properties. The LR domain was found to be involved in the nuclear localization of Vpr. In contrast, cell cycle arrest appears to be largely controlled by the C-terminal domain of Vpr. The LR and C- terminal domains do not appear to be essential for virion incorporation of Vpr. Interestingly, we found that two Vpr mutants harboring single amino acid substitutions (A30L and G75A) retained the ability to translocate to the nucleus but were impaired in the cell cycle arrest function. In contrast, mutation of Leu68 to Ser resulted in a protein that localizes in the cytoplasm while retaining the ability to arrest host cell proliferation. We speculate that the nuclear localization and cell cycle arrest functions of Vpr are not interrelated and that these functions are mediated by separable putative functional domains of Vpr.


This article has been cited by other articles:

  • Bolton, D. L., Lenardo, M. J. (2007). Vpr Cytopathicity Independent of G2/M Cell Cycle Arrest in Human Immunodeficiency Virus Type 1-Infected CD4+ T Cells. J. Virol. 81: 8878-8890 [Abstract] [Full Text]  
  • Nitahara-Kasahara, Y., Kamata, M., Yamamoto, T., Zhang, X., Miyamoto, Y., Muneta, K., Iijima, S., Yoneda, Y., Tsunetsugu-Yokota, Y., Aida, Y. (2007). Novel Nuclear Import of Vpr Promoted by Importin {alpha} Is Crucial for Human Immunodeficiency Virus Type 1 Replication in Macrophages. J. Virol. 81: 5284-5293 [Abstract] [Full Text]  
  • Mishra, S., Mishra, J. P., Kumar, A. (2007). Activation of JNK-dependent Pathway Is Required for HIV Viral Protein R-induced Apoptosis in Human Monocytic Cells: INVOLVEMENT OF ANTIAPOPTOTIC BCL2 AND c-IAP1 GENES. J. Biol. Chem. 282: 4288-4300 [Abstract] [Full Text]  
  • Varin, A., Decrion, A.-Z., Sabbah, E., Quivy, V., Sire, J., Van Lint, C., Roques, B. P., Aggarwal, B. B., Herbein, G. (2005). Synthetic Vpr Protein Activates Activator Protein-1, c-Jun N-terminal Kinase, and NF-{kappa}B and Stimulates HIV-1 Transcription in Promonocytic Cells and Primary Macrophages. J. Biol. Chem. 280: 42557-42567 [Abstract] [Full Text]  
  • Lai, M., Zimmerman, E. S., Planelles, V., Chen, J. (2005). Activation of the ATR Pathway by Human Immunodeficiency Virus Type 1 Vpr Involves Its Direct Binding to Chromatin In Vivo. J. Virol. 79: 15443-15451 [Abstract] [Full Text]  
  • Jin, S., Chen, C., Montelaro, R. C. (2005). Equine Infectious Anemia Virus Gag p9 Function in Early Steps of Virus Infection and Provirus Production. J. Virol. 79: 8793-8801 [Abstract] [Full Text]  
  • Varadarajan, P., Mahalingam, S., Liu, P., Ng, S. B. H., Gandotra, S., Dorairajoo, D. S. K., Balasundaram, D. (2005). The Functionally Conserved Nucleoporins Nup124p from Fission Yeast and the Human Nup153 Mediate Nuclear Import and Activity of the Tf1 Retrotransposon and HIV-1 Vpr. Mol. Biol. Cell 16: 1823-1838 [Abstract] [Full Text]  
  • Kamata, M., Nitahara-Kasahara, Y., Miyamoto, Y., Yoneda, Y., Aida, Y. (2005). Importin-{alpha} Promotes Passage through the Nuclear Pore Complex of Human Immunodeficiency Virus Type 1 Vpr. J. Virol. 79: 3557-3564 [Abstract] [Full Text]  
  • Rajendra Kumar, P., Singhal, P. K., Subba Rao, M. R. K., Mahalingam, S. (2005). Phosphorylation by MAPK Regulates Simian Immunodeficiency Virus Vpx Protein Nuclear Import and Virus Infectivity. J. Biol. Chem. 280: 8553-8563 [Abstract] [Full Text]  
  • Kino, T., Gragerov, A., Valentin, A., Tsopanomihalou, M., Ilyina-Gragerova, G., Erwin-Cohen, R., Chrousos, G. P., Pavlakis, G. N. (2005). Vpr Protein of Human Immunodeficiency Virus Type 1 Binds to 14-3-3 Proteins and Facilitates Complex Formation with Cdc25C: Implications for Cell Cycle Arrest. J. Virol. 79: 2780-2787 [Abstract] [Full Text]  
  • Sherman, M. P., de Noronha, C. M. C., Eckstein, L. A., Hataye, J., Mundt, P., Williams, S. A. F., Neidleman, J. A., Goldsmith, M. A., Greene, W. C. (2003). Nuclear Export of Vpr Is Required for Efficient Replication of Human Immunodeficiency Virus Type 1 in Tissue Macrophages. J. Virol. 77: 7582-7589 [Abstract] [Full Text]  
  • Ramanathan, M. P., Curley, E. III, Su, M., Chambers, J. A., Weiner, D. B. (2002). Carboxyl Terminus of hVIP/mov34 Is Critical for HIV-1-Vpr Interaction and Glucocorticoid-mediated Signaling. J. Biol. Chem. 277: 47854-47860 [Abstract] [Full Text]  
  • Mueller, S. M., Lang, S. M. (2002). The First HxRxG Motif in Simian Immunodeficiency Virus mac239 Vpr Is Crucial for G2/M Cell Cycle Arrest. J. Virol. 76: 11704-11709 [Abstract] [Full Text]  
  • Ayyavoo, V., Muthumani, K., Kudchodkar, S., Zhang, D., Ramanathan, P., Dayes, N. S., Kim, J. J., Sin, J.-I., Montaner, L. J., Weiner, D. B. (2002). HIV-1 viral protein R compromises cellular immune function in vivo. Int Immunol 14: 13-22 [Abstract] [Full Text]  
  • Jenkins, Y., Sanchez, P. V., Meyer, B. E., Malim, M. H. (2001). Nuclear Export of Human Immunodeficiency Virus Type 1 Vpr Is Not Required for Virion Packaging. J. Virol. 75: 8348-8352 [Abstract] [Full Text]  
  • Altfeld, M., Addo, M. M., Eldridge, R. L., Yu, X. G., Thomas, S., Khatri, A., Strick, D., Phillips, M. N., Cohen, G. B., Islam, S. A., Kalams, S. A., Brander, C., Goulder, P. J. R., Rosenberg, E. S., Walker, B. D. (2001). Vpr Is Preferentially Targeted by CTL During HIV-1 Infection. J. Immunol. 167: 2743-2752 [Abstract] [Full Text]  
  • Sova, P., Volsky, D. J., Wang, L., Chao, W. (2001). Vif Is Largely Absent from Human Immunodeficiency Virus Type 1 Mature Virions and Associates Mainly with Viral Particles Containing Unprocessed Gag. J. Virol. 75: 5504-5517 [Abstract] [Full Text]  
  • Zhu, Y., Gelbard, H. A., Roshal, M., Pursell, S., Jamieson, B. D., Planelles, V. (2001). Comparison of Cell Cycle Arrest, Transactivation, and Apoptosis Induced by the Simian Immunodeficiency Virus SIVagm and Human Immunodeficiency Virus Type 1 vpr Genes. J. Virol. 75: 3791-3801 [Abstract] [Full Text]  
  • D’Costa, J., Brown, H. M., Kundra, P., Davis-Warren, A., Arya, S. K. (2001). Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation. J. Gen. Virol. 82: 425-434 [Abstract] [Full Text]  
  • Sherman, M. P., de Noronha, C. M. C., Heusch, M. I., Greene, S., Greene, W. C. (2001). Nucleocytoplasmic Shuttling by Human Immunodeficiency Virus Type 1 Vpr. J. Virol. 75: 1522-1532 [Abstract] [Full Text]  
  • Mahalingam, S., Van Tine, B., Santiago, M. L., Gao, F., Shaw, G. M., Hahn, B. H. (2001). Functional Analysis of the Simian Immunodeficiency Virus Vpx Protein: Identification of Packaging Determinants and a Novel Nuclear Targeting Domain. J. Virol. 75: 362-374 [Abstract] [Full Text]  
  • Yoon, S., Kingsman, S. M., Kingsman, A. J., Wilson, S. A., Mitrophanous, K. A. (2000). Characterization of the equine infectious anaemia virus S2 protein. J. Gen. Virol. 81: 2189-2194 [Abstract] [Full Text]  
  • Sherman, M. P., de Noronha, C. M. C., Pearce, D., Greene, W. C. (2000). Human Immunodeficiency Virus Type 1 Vpr Contains Two Leucine-Rich Helices That Mediate Glucocorticoid Receptor Coactivation Independently of Its Effects on G2 Cell Cycle Arrest. J. Virol. 74: 8159-8165 [Abstract] [Full Text]  
  • Kamata, M., Aida, Y. (2000). Two Putative alpha -Helical Domains of Human Immunodeficiency Virus Type 1 Vpr Mediate Nuclear Localization by at Least Two Mechanisms. J. Virol. 74: 7179-7186 [Abstract] [Full Text]  
  • Zhou, Y., Ratner, L. (2000). Phosphorylation of Human Immunodeficiency Virus Type 1 Vpr Regulates Cell Cycle Arrest. J. Virol. 74: 6520-6527 [Abstract] [Full Text]  
  • Nishizawa, M., Kamata, M., Katsumata, R., Aida, Y. (2000). A Carboxy-Terminally Truncated Form of the Human Immunodeficiency Virus Type 1 Vpr Protein Induces Apoptosis via G1 Cell Cycle Arrest. J. Virol. 74: 6058-6067 [Abstract] [Full Text]  
  • Pancio, H. A., Vander Heyden, N., Ratner, L. (2000). The C-Terminal Proline-Rich Tail of Human Immunodeficiency Virus Type 2 Vpx Is Necessary for Nuclear Localization of the Viral Preintegration Complex in Nondividing Cells. J. Virol. 74: 6162-6167 [Abstract] [Full Text]  
  • Kichler, A., Pages, J.-C., Leborgne, C., Druillennec, S., Lenoir, C., Coulaud, D., Delain, E., Le Cam, E., Roques, B. P., Danos, O. (2000). Efficient DNA Transfection Mediated by the C-Terminal Domain of Human Immunodeficiency Virus Type 1 Viral Protein R. J. Virol. 74: 5424-5431 [Abstract] [Full Text]  
  • Masuda, M., Nagai, Y., Oshima, N., Tanaka, K., Murakami, H., Igarashi, H., Okayama, H. (2000). Genetic Studies with the Fission Yeast Schizosaccharomyces pombe Suggest Involvement of Wee1, Ppa2, and Rad24 in Induction of Cell Cycle Arrest by Human Immunodeficiency Virus Type 1 Vpr. J. Virol. 74: 2636-2646 [Abstract] [Full Text]  
  • Shenker, B. J., McKay, T., Datar, S., Miller, M., Chowhan, R., Demuth, D. (1999). Actinobacillus actinomycetemcomitans Immunosuppressive Protein Is a Member of the Family of Cytolethal Distending Toxins Capable of Causing a G2 Arrest in Human T Cells. J. Immunol. 162: 4773-4780 [Abstract] [Full Text]  
  • Chen, M., Elder, R. T., Yu, M., O'Gorman, M. G., Selig, L., Benarous, R., Yamamoto, A., Zhao, Y. (1999). Mutational Analysis of Vpr-Induced G2 Arrest, Nuclear Localization, and Cell Death in Fission Yeast. J. Virol. 73: 3236-3245 [Abstract] [Full Text]  
  • SHIMURA, M., TANAKA, Y., NAKAMURA, S., MINEMOTO, Y., YAMASHITA, K., HATAKE, K., TAKAKU, F., ISHIZAKA, Y. (1999). Micronuclei formation and aneuploidy induced by Vpr, an accessory gene of human immunodeficiency virus type 1. FASEB J. 13: 621-637 [Abstract] [Full Text]  
  • Bachand, F., Yao, X.-J., Hrimech, M., Rougeau, N., Cohen, E. A. (1999). Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Requires a Direct Interaction with the p6 Domain of the p55 Gag Precursor. J. Biol. Chem. 274: 9083-9091 [Abstract] [Full Text]  
  • Kulkosky, J., Laptev, A., Shetty, S., Srinivasan, A., BouHamdan, M., Prockop, D. J., Pomerantz, R. J. (1999). Human Immunodeficiency Virus Type 1 Vpr Alters Bone Marrow Cell Function. Blood 93: 1906-1915 [Abstract] [Full Text]  
  • Willetts, K. E., Rey, F., Agostini, I., Navarro, J.-M., Baudat, Y., Vigne, R., Sire, J. (1999). DNA Repair Enzyme Uracil DNA Glycosylase Is Specifically Incorporated into Human Immunodeficiency Virus Type 1 Viral Particles through a Vpr-Independent Mechanism. J. Virol. 73: 1682-1688 [Abstract] [Full Text]  
  • Kino, T., Gragerov, A., Kopp, J. B., Stauber, R. H., Pavlakis, G. N., Chrousos, G. P. (1999). The HIV-1 Virion-associated Protein Vpr Is a Coactivator of the Human Glucocorticoid Receptor. JEM 189: 51-62 [Abstract] [Full Text]  
  • Jenkins, Y., McEntee, M., Weis, K., Greene, W. C. (1998). Characterization of HIV-1 Vpr Nuclear Import: Analysis of Signals and Pathways. JCB 143: 875-885 [Abstract] [Full Text]  
  • Yedavalli, V. R. K., Chappey, C., Ahmad, N. (1998). Maintenance of an Intact Human Immunodeficiency Virus Type 1 vpr Gene following Mother-to-Infant Transmission. J. Virol. 72: 6937-6943 [Abstract] [Full Text]  
  • Okui, N., Kobayashi, N., Kitamura, Y. (1998). Production of Uninfectious Human Immunodeficiency Virus Type 1 Containing Viral Protein R Fused to a Single-Chain Antibody against Viral Integrase. J. Virol. 72: 6960-6964 [Abstract] [Full Text]  
  • Kobinger, G. P., Borsetti, A., Nie, Z., Mercier, J., Daniel, N., Gottlinger, H. G., Cohen, E. A. (1998). Virion-Targeted Viral Inactivation of Human Immunodeficiency Virus Type 1 by Using Vpr Fusion Proteins. J. Virol. 72: 5441-5448 [Abstract] [Full Text]  
  • Fouchier, R. A. M., Meyer, B. E., Simon, J. H. M., Fischer, U., Albright, A. V., Gonzalez-Scarano, F., Malim, M. H. (1998). Interaction of the Human Immunodeficiency Virus Type 1 Vpr Protein with the Nuclear Pore Complex. J. Virol. 72: 6004-6013 [Abstract] [Full Text]  
  • Nie, Z., Bergeron, D., Subbramanian, R. A., Yao, X.-J., Checroune, F., Rougeau, N., Cohen, E. A. (1998). The Putative Alpha Helix 2 of Human Immunodeficiency Virus Type 1 Vpr Contains a Determinant Which Is Responsible for the Nuclear Translocation of Proviral DNA in Growth-Arrested Cells. J. Virol. 72: 4104-4115 [Abstract] [Full Text]  
  • Subbramanian, R. A., Kessous-Elbaz, A., Lodge, R., Forget, J., Yao, X.-J., Bergeron, D., Cohen, E. A. (1998). Human Immunodeficiency Virus Type 1 Vpr Is a Positive Regulator of Viral Transcription and Infectivity in Primary Human Macrophages. JEM 187: 1103-1111 [Abstract] [Full Text]  
  • Mahalingam, S., Ayyavoo, V., Patel, M., Kieber-Emmons, T., Kao, G. D., Muschel, R. J., Weiner, D. B. (1998). HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 95: 3419-3424 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»